Literature DB >> 7525697

High prevalence of hepatitis C virus RNA in the supernatant and the cryoprecipitate of patients with essential and secondary type II mixed cryoglobulinemia.

P Bichard1, A Ounanian, M Girard, C Baccard, A Rolachon, J C Renversez, D Cordonnier, J M Seigneurin, J L Debru, J P Zarski.   

Abstract

Detection of hepatitis C virus RNA by polymerase chain reaction was performed in 26 patients with type II mixed cryoglobulinemia, and compared with anti-HCV antibody detection. The patients were divided into two groups according to etiology: 15 had essential type II mixed cryoglobulinemia and 11 had secondary type II mixed cryoglobulinemia. In the essential type II mixed cryoglobulinemia group, the prevalence of hepatitis C virus RNA detected by polymerase chain reaction was 60% in the supernatant and 93% in the cryoprecipitate. In the secondary type II mixed cryoglobulinemia group the prevalence of hepatitis C virus RNA was 45% in the supernatant and 55% in the cryoprecipitate. The differences between the two groups were not statistically significant. In both patient groups, detection of hepatitis C virus RNA in the cryoprecipitate was the most sensitive test for hepatitis C virus infection. These results suggest that hepatitis C virus might be involved in the origin of mixed cryoglobulinemia.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7525697     DOI: 10.1016/s0168-8278(94)80137-1

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  7 in total

Review 1.  Hepatitis C virus infection and lymphoproliferative disorders.

Authors:  L R Peña; S Nand; N De Maria; D H Van Thiel
Journal:  Dig Dis Sci       Date:  2000-09       Impact factor: 3.199

2.  Clinical guidelines on the management of hepatitis C.

Authors:  J C Booth; J O'Grady; J Neuberger
Journal:  Gut       Date:  2001-07       Impact factor: 23.059

3.  Cryoglobulins are not essential.

Authors:  M Trendelenburg; J A Schifferli
Journal:  Ann Rheum Dis       Date:  1998-01       Impact factor: 19.103

Review 4.  Hepatitis C virus-induced cryoglobulinemia.

Authors:  Edgar D Charles; Lynn B Dustin
Journal:  Kidney Int       Date:  2009-07-15       Impact factor: 10.612

5.  Lesson from an intriguing case of cryoglobulinemia.

Authors:  Michele Barone; Raffaele Licinio; Annabianca Amoruso; Maria Teresa Viggiani; Angela Maria Vittoria Larocca; Alfredo Di Leo
Journal:  World J Gastroenterol       Date:  2013-01-14       Impact factor: 5.742

Review 6.  Q fever endocarditis masquerading as Mixed cryoglobulinemia type II. A case report and review of the literature.

Authors:  Petros I Rafailidis; Spiros P Dourakis; Christos A Fourlas
Journal:  BMC Infect Dis       Date:  2006-02-23       Impact factor: 3.090

7.  Persistent Hepatitis C Virus-Associated Cryoglobulinemic Glomerulonephritis in Patients Successfully Treated With Direct-Acting Antiviral Therapy.

Authors:  Dominick Santoriello; Nanda K Pullela; Kalpana A Uday; Shawn Dhupar; Jai Radhakrishnan; Vivette D D'Agati; Glen S Markowitz
Journal:  Kidney Int Rep       Date:  2018-04-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.